The importance of cost considerations in preterm birth trials

Abstract

As evidence-informed healthcare continues to advance, understanding the complexities of cost-effective interventions becomes increasingly important. Both new innovations and traditional therapies are being considered through a lens of costs and benefits. This can be particularly difficult when it comes to preventive interventions as the cost savings from prevention of later events can be difficult to calculate. This article is protected by copyright. All rights reserved.